Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Contraception|October 1, 1995
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and toleranceJ Endrikat, M A Jaques, M Mayerhofer, et al.
Contraception|December 19, 2001
A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids, and carbohydrate metabolismJ Endrikat, C Klipping, C Gerlinger, et al.
Contraception|February 19, 2004
A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral densityJ Endrikat, E Mih, B Düsterberg, et al.
Contraception|August 1, 1996
Shorter pill-free interval in combined oral contraceptives decreases follicular developmentJ Spona, M Elstein, W Feichtinger, et al.
Contraception|April 4, 2002
An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variablesJan Endrikat, C Klipping, M Cronin, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 10, 2003
A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive useJ Endrikat, C Gerlinger, K Plettig, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 19, 2002
Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intakeJ Endrikat, C Gerlinger, M Cronin, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 3, 2003
Recommendation for confidence interval and sample size calculation for the Pearl IndexC Gerlinger, J Endrikat, E A van der Meulen, et al.
Contraception|December 19, 2001
Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparationsJ Endrikat, M Noah, C Gerlinger, et al.
Contraception|January 1, 1981
Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal womenG B Melis, F Strigini, F Fruzzetti, et al.
Pageof 4